Back
BioCardia Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
41
BCDA
BioCardia
Last Price:
3.00
Seasonality Move:
29.18%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
276.54
Seasonality Move:
5.61%
Sell
41
BioCardia (BCDA)
is a Sell
Is BioCardia a Buy, Sell or Hold?
- The current BioCardia [BCDA] share price is $2.99. The Score for BCDA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BCDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $276.33. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCDA Stock Price Chart
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $276.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
BCDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.32 | Buy |
| Chaikin Money Flow: | -248676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.42 - 3.3) | Buy |
| Bollinger Bands (100): | (2.49 - 4.85) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 60.54 | Buy |
| Chaikin Money Flow: | -66637 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.89 - 278.47) | Buy |
| Bollinger Bands (100): | (164.63 - 269.71) | Buy |
BCDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.84 | Buy |
| 20-day SMA: | 2.75 | Buy |
| 50-day SMA: | 2.89 | Buy |
| 200-day SMA: | 5.49 | Sell |
| 8-day EMA: | 2.87 | Buy |
| 20-day EMA: | 2.82 | Buy |
| 50-day EMA: | 3.02 | Sell |
| 200-day EMA: | 6.18 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 267.42 | Buy |
| 20-day SMA: | 266.35 | Buy |
| 50-day SMA: | 259.79 | Buy |
| 200-day SMA: | 191.66 | Buy |
| 8-day EMA: | 269.14 | Buy |
| 20-day EMA: | 265.86 | Buy |
| 50-day EMA: | 253.52 | Buy |
| 200-day EMA: | 208.02 | Buy |
BioCardia Earnings Growth & BCDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and an increase next year of $0.08 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
BioCardia Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||